×
Customize
Start
Cancer Types
Quick Links
Award Programs
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Overcoming the Odds: Steven's Journey with Stage IV RCC
Karl J. D’Silva, MD, and Steven Gallant, a stage IV renal cell cancer survivor, discuss the journey to overcoming aggressive and metastatic disease with cabozantinib, and consider effective measures to managing toxicities.
Episode 1 The Diagnosis of a Patient with Stage 4 Renal Cell Cancer
Karl J. D’Silva, M.D., and Steven Gallant discuss the process of being diagnosed with stage 4 renal cell cancer.
Episode 2 Advice for Patients with RCC Choosing a Treatment Option
Episode 3 Frontline Treatment Options for Stage 4 RCC
Episode 4 Undergoing Treatment: Cabozantinib Toxicity Management
Episode 5 Cabozantinib Dose Modification
Episode 6 The Impact of Support Networks & Multidisciplinary Care
Episode 7 The Typical Prognosis of Aggressive Renal Cell Cancer